In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

VIDEOS

We are very excited to bring to you more information through our new program regarding supportive care in cancer treatment. Arjun Gupta, MD, one of...

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

We are very excited to bring to you this new program on supportive care in cancer treatment. Arjun Gupta, MD, one of the GRACE Fellows Ambassador...

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor...

ARTICLES

With the plethora of Medicare options available, here is an overview of Medicare terms and options along with things to consider when choosing a...

From the Grace Archives | Originally Published March 18, 2007 | By Dr. West Between 7 and 15% of patients with lung cancer develop a malignant pleural...
From the Grace Archives | Originally Published March 18, 2007 | By Dr. West Between 7 and 15% of patients with lung cancer develop a malignant pleural...
From the Grace Archives | Originally Published November 12, 2014 | By Dr. Weiss | Leave a comment Smoking is the most common cause of lung cancer; 85%...
From the Grace Archives | Originally Published November 12, 2014 | By Dr. Weiss | Leave a comment Smoking is the most common cause of lung cancer; 85%...

COMMUNITY FORUM

Hi! Just realized I hadn't posted in a while and wanted to send a brief update and a big thanks for Thanksgiving (a few days late). All is still going...
Happy Sunday all. I'm new and trying to figure what is going on with me and an "incidental" finding from February 21, 2020. I have a host of spine...
Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination...
Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination...
Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination...

Recent Comments

Hi Berta, I could not find…
Comment By dbrock on Jun 14, 2023 2:52 pm
Hi Tammy,  Welome to Grace. …
Comment By JanineT GRACE … on May 16, 2023 1:48 pm
Concerned
Comment By JanineT GRACE … on May 16, 2023 1:48 pm
Hi Caregiver and welcome to…
Comment By JanineT GRACE … on May 12, 2023 2:22 pm

Progession on Tagrisso?

Forums

I've been on Tagrisso since July 2017. I had great initial response with all visible cancer shrinking to the point of no longer being detected except for one solitary nodule that shrank from 1.8 cm to .6 cm.  In August 2018, a scan showed the nodule had doubled in size in 10 weeks and a met appeared on a rib. The nodule was radiatied. Scans Dec 2018 showed the nodule had again reduced to about .5 cm, the rib met remained stable and another rib met appeared to be developing.

Lung Cancer Video Library Mandarin - Chemotherapy Immunotherapy Combinations in Advanced Non-Squamous NSCLC

Video

For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library. 

In this video translation, Dr. Li discusses immunotherapy combinations in advanced non-squamous non small cell lung cancer.

 

PET scan kidney value requirement

My husband has the following values for kidney function:

Creatinine:   1.36   (normal range .8 - 1.25)

         Urea:     68   (normal range 15 - 53)

Would these values be generally acceptable   to get a PET/CT scan ?  to be ok getting the

dye/glucose injections?   If so, should he get iv fluids before and/or after the injection to

assist in flushing the kidneys?

We are in Greece and I don't see a EGFR or BUN listed on his bloodwork, just these #'s

 

Chance of Cure in Advanced Cancer: What do Older Patients Believe

Article

At ASCO 2018, Dr. Melissa Loh presented a study titled: "Chance of Cure in Advanced Cancer: What Do Older Patients Believe and How Are These Beliefs Related to Their Preferences?".  This study looked at patients and their beliefs regarding a cure for cancer, specifically in older patients with advanced cancer.  Patients who are certain that they could be cured pose unique challenges for physicians and shows a need for clear communication between patients and their physicians regarding the outcome of treatment and quality of life.

ASCO 2018 - Dream Study - Chemo with Imfinzi (Durvalumab) for Mesothelioma

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss the Dream Study - combining chemotherapy with Imfinzi (Durvalumab) for mesothelioma.

ASCO 2018 - Keynote 158 - Keytruda in Previously Treated, Now Relapsing Patients with SCLC

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss Keynote 158 - treating with Keytruda in previously treated, now relapsing patients with SCLC.

ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the Jury Still Out

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss if the jury is still out in regard to combining Metformin with standard EGFR therapy.

ASCO 2018 - Tarceva Combined with Carboplatin & Alimta - Given Upfront Will it Affect Pace of Disease?

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

In this roundtable video, the doctors discuss Tarceva combined with carboplatin and Alimta, if it is given upfront will it affect the pace of the disease?

ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Positive NSCLC vs. Tagrisso or Vizimpro

Video

Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.

Subscribe to In Treatment